CU Cancer Center welcomes 12 new members

The University of Colorado Cancer Center is pleased to welcome the following new members!

Clay Smith, MDClayton Smith, MD, Full Member, Molecular Oncology

Professor, Department of Hematology/BMT, CU SOM

  • Primary Research Interests: Hematology/BMT
  • Recent publication: “An acute negative bystander effect of y-irradiated recipients on transplanted hematopoetic stem cells” (Blood, 2012)
  • Education: Fellowships, Memorial Sloan Kettering and Stanford University; MD, Southwestern Medical School, Dallas, TX; BA, Rice University

 

 

Cindy O'Bryant, PharmD

Cindy L O’Bryant, PharmD, Full Member, Developmental Therapeutics

Associate Professor, Clinical Oncology, CU SOM

  • Primary Research Interests: Developmental Therapeutics, GI Cancer
  • Recent publication: “An open label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function” (Cancer Chemother Pharmacol, 2011)
  • Education: PharmD, Mercer University Southern School of Pharmacy; BS, University of Tennessee, Knoxville

 

Xiang.WangXiang Wang, PhD, Full Member, Developmental Therapeutics

Assistant professor, Department of Organic Chemistry, CU Boulder

  • Primary Research Interests: Unspecified
  • Recent publication: “A one-pot three-component reaction for the preparation of highly functionalized tryptamines” (Tetrahedron, 2012)
  • Education: Postdoc, Harvard University; PhD, Boston University; BS, University of Science and Technology of China, Hefei.

 

John Arcaroli, PhD, Associate Member, Developmental Therapeutics

Assistant professor, Medical Oncology, CU SOM

  • Primary Research Interests: GI Cancer
  • Recent publication: “Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of caracatin oral Src inhibitor, in previously treated pancreatic cancer” (Cancer Medicine, 2012)
  • Education: PhD, University of Colorado Health Sciences Center; MS, University of Nebraska Medical Center; BS, University of Nebraska-Lincoln.

 

Melanie Joy, PhD, PharmD, Associate Member, Developmental Therapeutics

Assistant professor, Skaggs School of Pharmacy and Pharmaceutical Sciences

  • Primary Research Interests: Kidney Toxicity
  • Recent publication: “Cyclophosphamide and 4-Hydroxyxyclophosphamide pharmokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis” (Br J Clin Pharmacol)
  • Education: PhD, University of North Carolina, Chapel Hill; PharmD, Duquesne University; BS, University of Pittsburgh

 

Hong Wang, MD, PhD, Associate Member, Hormone Related Malignancies

Research Instructor, Department of Surgery, CU SOM

  • Primary Research Interests: Bladder and Prostate Cancers
  • Recent publication: “Translation initiation factor elF3b expression in human cancer and its role in tumor growth and lung colonization” (Clin Cancer Res., 2012)
  • Education: PhD, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; MS, West China College of Medicine; MD, West China College of Medicine

 

Katja Vassiliades- Kiseljak, D.O., Associate Member, Endocrinology, Metabolism and Diabetes

Instructor, CU SOM

  • Primary Research Interests: Endocrine Neoplasms
  • Recent publication: “Reprimo (RPRM) is a novel tumor suppressor ain pituitary gland tumors and regulates survival, proliferation and tumorigenicy” (Endocrinology, 2011)
  • Education: Residency, Johns Hopkins University; DO, Midwestern University; BA Bethany College

 

James Daniel Orth, PhD, Associate Member, Cancer Cell Biology
Assistant Research Professor, MCDB, CU Boulder

  • Primary Research Interests: Developmental Therapeutics, GI Cancer, Sarcomas
  • Recent publication: “Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction” (Mol Biol Cell, 2012)
  • Education: Postdoc, Harvard University; PhD, Mayo Clinic College of Medicine; BS, University of Wisconsin, Eau Claire

 

Rebecca Oberley-Deegan, PhD, Associate Member, Cancer Cell Biology

Assistant professor, Pulmonary Medicine, National Jewish Health

  • Primary Research Interests: Prostate Cancer, Radiation Oncology
  • Recent publication: “The antioxidant, Mn TE-2-PyP, prevents side-effects incurred by prostate cancer irradiation” (PLoS ONE, 2012)
  • Education: PhD, University of Iowa; BA Grinnell College

Barish H Edil, MD, Associate Member, Developmental Therapeutics

Associate Professor, Surgical Oncology, CU SOM

  • Primary Research Interests: GI Cancer
  • Recent publication: “Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement (Human Pathology, 2012)
  • Education: MD, University of Wisconsin School of Medicine; BS, University of Wisconsin

 

Miriam Post, MD, Associate Member, Hormone Related Malignancies

Assistant professor, Pathology, CU SOM

  • Primary Research Interests: Breast Cancer, GYN Oncology, Hereditary Cancer
  • Recent publication: “Cutaneous decidualized endometriosis in a non-pregnant female: a potential pseudomalignancy” (Am J Dermopathology, 2012)
  • Education: Fellowship, Mass General; MD, Jefferson Medical College; BA Cornell University

 

Daniel Bowles, MD, Associate Member, Lung/Head and Neck Cancer

Assistant professor, Medical Oncology, Denver VA Medical Center

  • Primary Research Interests: Developmental Therapeutics, Head and Neck Cancer
  • Recent publication: “Vismodegin in basal cell carcinoma” (Drugs Today, 2012)
  • Education: MD, University of Colorado SOM; BA, Kenyon College
FacebookTwitterGoogle+Share

About the author: Garth Sundem

In addition to writing for the University of Colorado Cancer Center, Garth is the author of the books The Geeks' Guide to World Domination, Brain Candy, and Geek Logik. Contact him at garth.sundem [at] ucdenver.edu.

2 comments

  1. Jim Stevens says:

    I don’t think that the subject of the picture has anything to do with the treatment for bladder cancer (or who knows maybe it might) but the picture of the kelp bulb is awesome. Who took it. As a child I played with that stuff everytime I went to the beach. Sun dried it results in stiff tubes and you can play like a tuba. If it is an original by one of our CC members, I would love to get a reprint of it for framing.

    Jim